CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-09 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −10,000 | 20,000 | ||
| 2017-03-06 | Sardesai Niranjan Chief Operating Officer | Shares withheld for taxes | −3,067 | $6.95 | $21K | 63,513 |
| 2017-03-06 | KIES PETER CFO | Shares withheld for taxes | −3,640 | $6.95 | $25K | 31,219 |
| 2017-03-06 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −3,067 | $6.95 | $21K | 25,758 |
| 2017-03-06 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −4,365 | $6.95 | $30K | 1,964,610 |
| 2017-03-05 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +8,333 | 66,580 | ||
| 2017-03-05 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Restricted Stock Unit | −8,333 | 8,333 | ||
| 2017-03-05 | KIES PETER CFO | Exercise or conversion | +8,333 | 34,859 | ||
| 2017-03-05 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −8,333 | 8,333 | ||
| 2017-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +8,333 | 28,825 | ||
| 2017-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −8,333 | 8,333 | ||
| 2017-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +13,333 | 1,968,975 | ||
| 2017-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −13,333 | 13,333 | ||
| 2017-01-04 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +6,133 | $6.12 | $38K | 54,567 |
| 2017-01-04 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +3,680 | $6.12 | $23K | 58,247 |
| 2017-01-04 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Common Stock Option | −6,133 | 0 | ||
| 2017-01-04 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Common Stock Option | −3,680 | 0 | ||
| 2016-08-29 | Sardesai Niranjan Chief Operating Officer | Sale | −21,800 | $9.30 | $203K | 48,434 |
| 2016-08-28 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +33,116 | $6.12 | $203K | 70,234 |
| 2016-08-28 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Common Stock Options | −33,116 | 0 |
Page 47 of 49 · 961 trades